A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396

Clinical trial NCT04246190 · UNKNOWN

Trial details

NCT number: NCT04246190
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Type2 Diabetes Mellitus

Start date: 2020-02-24
Primary completion: 2020-04-10
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.